clinical-variant-prioritizer
SkillAI & modelsScreens a genotype set against disease-gene panels for variant prioritisation, ranking carried variants by actionability.
Available today. Use it from your connected AI after setup.
No other account needed.
Add ahel to your AI once: Claude, ChatGPT, Cursor, Claude Code or Codex. Then ask it to use this.
Then ask your AI: use the clinical-variant-prioritizer skill
About this skill
Screen a genotype set (array or WGS-derived) against OMIM-morbid, ACMG-SF and Hereditary-Cancer gene panels and prioritise carried variants by ClinVar significance, gnomAD frequency, inheritance model and zygosity, following the pathogenicity-screening method of Corpas et al. 2021 (Whole Genome Inte
What this skill tells your AI
The instructions your AI receives, as published by clawbio/clawbio in skills/clinical-variant-prioritizer/SKILL.md and read by ahel’s review.
Turn a genotype set into a prioritised list of clinically relevant variants, the way a clinical genome analyst would: screen catalogued disease-gene panels, then rank what is carried by how much it matters, not by how loud the raw ClinVar label is.
This skill implements the pathogenicity-screening stage of Whole Genome Interpretation for a Family of Five (Corpas et al., Front Genet 2021): variants are filtered through OMIM-morbid, ACMG-SF and Hereditary-Cancer panels, intersected with ClinVar significance and gnomAD population frequency, and classified by inheritance model and zygosity.
Why it is not a raw ClinVar lookup
A raw lookup reports a label. This skill reports actionability. The same "pathogenic" allele means very different things depending on context:
| Context | Category |
|---|---|
| Dominant / risk gene, allele carried | actionable |
| Recessive gene, homozygous | affected |
| Recessive gene, heterozygous | carrier (reproductive-risk only) |
| Uncertain / conflicting ClinVar | uncertain (flagged, not acted on) |
| Benign allele carried | benign |
| Variant not carried | reference |
A heterozygous carrier of a common, recessive, benign-spectrum allele is not an actionable finding, even when ClinVar shows "pathogenic" submissions. Saying so plainly is the point.
Interface
from api import run
result = run(
{"rs28941785": "CT", "rs1800562": "GG"}, # rsid -> genotype
options={"panel_path": "..."}, # optional custom panel
)
run() returns:
summary:panel_size,loci_tested,loci_carried,reference,not_tested, and per-category counts (actionable,affected,carriers,uncertain,benign).findings: ranked list (highest priority first); each carries gene, HGVS, consequence, genotype, zygosity, ClinVar significance + review status, gnomAD frequency, condition, inheritance, panel membership, category and a plain-languagerationale.headline,method,disclaimer.
Panel
data/clinical_panel.json is a curated set of catalogued clinical loci, each
shipping its ClinVar significance, ClinVar review status, gnomAD frequency,
consequence, condition and inheritance model, so the screen is deterministic and
offline-reproducible (no per-call ClinVar/gnomAD/VEP network round-trips). Extend
it by adding entries; keys may be rsids or stable variant ids for WGS-only
variants not present on arrays.
Limitations
Array-based input covers only catalogued loci and misses most rare variants; a clean screen is not a clean genome. Heterozygous calls do not establish phase. Confirm any finding with an accredited clinical assay. Research and educational use only; not a clinical diagnosis.
Test
python -m pytest tests/ -q
Signals
- GitHub stars
- 1k
- Forks
- 277
- Last commit
- Sep 2026
Advanced
- Item type
- skill
- Key
clinical-variant-prioritizer- Source
- github.com/clawbio/clawbio